Charles River Laboratories India

Endosafe^®
Endotoxin Testing

Celsis^®
Rapid Microbial Detection

Accugenix^®
Microbial identification
and strain typing

Receiving reliable and accurate endotoxin test results quickly is important to your lab. For more than 50 years since its discovery, the Limulus amebocyte lysate (LAL) test has been the gold standard, with over 70 million tests performed annually without a single FDA-confirmed pyrogenic outbreak due to a false-negative.

We offer a wide range of FDA-licensed products for traditional and rapid bacterial endotoxin testing to reduce retest rates and improve turnaround times so you can make prompt, confident decisions about the safety of your products.

Cartridge, kinetic, or gel-clot? Whatever you're testing, whichever testing method you choose, Charles River's Endosafe^® reagents have you covered. See which one is best for your organization.

Not all rapid microbial methods are created equal, and neither are suppliers. Choosing a rapid method takes more time, energy, and money than ever before, so it’s important to make sure you’re making the right decision for your products, lab, and ultimately, your company.

Celsis^® systems deliver quality assurance results in just 18–24 hours, enabling you to rapidly confirm the sterility of your product and quickly release to market. This eliminates days from your inventory requirements and production cycle times, reduces warehousing and working capital requirements, and improves your overall profitability.

We are here to help explore your options. For over 10 years, rapid microbial screening systems such as the Celsis Advance II™ and Celsis Accel™ have provided operational value to small and medium-size pharmaceutical and consumer care manufacturers.

Accurate and timely microbial identification is crucial for tracking and trending environmental monitoring (EM) data that guides critical decisions and protects you from releasing contaminated products. Accurate microbial identification requires continuous process refinements, timely updates to organism libraries that reflect current taxonomy and classification, and expertise in interpreting data.

Encompassing over 8,000 relevant bacterial and 4,000 fungal species, our Accugenix^® libraries are continually updated based on frequently occurring organisms in facilities around the world.

AccuGENX-ID^® sequence-based genotypic microbial identification services are considered the industry’s "gold standard" methods of choice for applications such as high-risk manufacturing, sterility failures, final product releases, and testing for sterile fill facilities. The AccuPRO-ID^® MALDI-TOF identification service is a better alternative to outdated phenotypic methods when identifying routine EM samples.